Non-Communicable Disease Burden in Syria: A Cross-Sectional Study of Internal Medicine Challenges, Trends, and Prospects

Dr. Abdulah Mohammad Abd Alhamed Abou Kaff, Dr. Abdalghani Fuad Mukhalalati, Dr. Fatema Nadem Soufe, Dr. Yousef Feras Issam Mahroom, Dr. Abdullah Farid Al Hraki

Abstract


Background: Syria is affected by an unequal emergence of NCDs exacerbated by over a decade of armed conflict, disruption of health systems, displacement and collapse due to socio-economic pressure. Pre and post the war period, NCDs are responsible for about 77% of all deaths in-country with cardiovascular diseases (CVD), Type 2 Diabetes Mellitus (T2DM), chronic respiratory disorders and cancer have been reported as the major contributors [9]. All of this has resulted in the current crisis which is responsible for major NCD prevention, surveillance, and management disruption and constitutes a public health emergency requiring evidence-based actions at all levels from internal medicine practitioners to policymakers. Objective: To systematically characterise the contemporary burden of non-communicable diseases (NCDs) in Syria, quantify pooled prevalence estimates, delineate factors associated with these estimates and examine challenges and prospects for practice appropriate internal medicine in the Syrian context. Methods: PubMed/MEDLINE, Scopus, Embase, Cochrane Library and Google Scholar were systematically accessed. Cross-sectional studies, cohort studies, retrospective analyses, systematic and scoping reviews available in peer-reviewed international journals from January 2020 to November 2025 that report data on prevalence or risk factors of non-communicable diseases (NCD) either in Syria or for Syrian populations. Since heterogeneity was anticipated, random-effects meta-analytic model (DerSimonian-Laird method) was utilised. Pooled prevalence estimates (PEs) with 95% confidence intervals (CIs) were used. The I² statistic was used to quantify heterogeneity. Results: In qualitative synthesis, 51 studies were included; in meta-analysis, 32 eligible studies encompassed data from 237,723 participants across conflict-affected Syrian populations and displaced Syrian communities. Conclusion: An interminable humanitarian crisis underpins an alarming NCD epidemic in Syria. The aggregated prevalence data show that Syrian populations bear high, yet heterogeneous, burdens of cardiometabolic disease and chronic disease. Immediate prioritisation of services for NCDs, a strengthened workforce and restored supply of medicines needs to be supported by integrated health information systems in order to reduce avoidable mortality and morbidity. Longitudinal, nationally representative designs are essential for future research to fill critical evidence gaps.

Keywords


Non-Communicable Diseases; Syria; Internal Medicine; Cardiovascular Disease; Diabetes Mellitus; Conflict-Affected Populations

Full Text:

PDF

References


REFERENCES

World Health Organization. Noncommunicable diseases [Internet]. Geneva: WHO; 2024 [cited 2025 Apr 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

GBD 2021 Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10434):2129–74.

Rastam S, Al Ali R, Maziak W, et al. Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health. 2013;13:507.

Maziak W, Taleb ZB, Bahelah R, et al. The global epidemiology of waterpipe smoking. Tob Control. 2015;24(Suppl 1):i3–12.

United Nations High Commissioner for Refugees (UNHCR). Syria Emergency [Internet]. Geneva: UNHCR; 2024 [cited 2025 Mar 15]. Available from: https://www.unhcr.org/syria-emergency.html

World Health Organization, Regional Office for the Eastern Mediterranean. Syrian Arab Republic: Public Health Situation Analysis (PHSA). Cairo: WHO EMRO; 2022.

Garry S, Pringle J, Almustafa M, et al. Access to essential medicines for noncommunicable diseases during conflicts: The case of cardiovascular diseases, diabetes and epilepsy in Northern Syria. PLoS One. 2025 [Epub ahead of print].

Akik C, Ghattas H, Mesmar S, et al. Host country responses to non-communicable diseases amongst Syrian refugees: a systematic review. Confl Health. 2019;13:8.

Naja F, Shatila H, El Koussa M, Meho L, Ghandour L, Saleh S. Burden of non-communicable diseases among Syrian refugees: a scoping review. BMC Public Health. 2019;19(1):637.

Al-Abdulla O, Alaref M, Kallström A, Kauhanen J. The health system in Syria (2000–2024): assembling the pieces of a fragmented system a scoping review. Health Res Policy Syst. 2025;23(1):85.

Al-Jumaili AA, Al-Jumaili MK, Al-Ani R, et al. The prevalence of non-communicable diseases among Syrian refugees in Syria’s neighbouring host countries: a systematic review and meta-analysis. Public Health. 2022;205:107–15.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.

Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa: Ottawa Hospital Research Institute; 2013 [cited 2025 Feb 10]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203.

Almansouri T, Alazraki M, Hayaly RI, Sinjab A, Akhras M, Marhoum El Filali K. Outpatient cardiovascular diseases and diabetes medicines dispensing in the population with government health insurance in Syria between 2018 and 2019: a retrospective analysis. BMC Health Serv Res. 2021;21(1):1009.

Abdo N, Almasaid S, Alhemedi AJ, et al. A nationwide comparative analysis of the prevalence and determinants of non-communicable diseases risk factors between Jordanian and displaced Syrian populations. BMC Public Health. 2025;25(1):1862.

International Diabetes Federation. IDF Diabetes Atlas, 10th edition [Internet]. Brussels: IDF; 2021 [cited 2025 Jan 20]. Available from: https://www.diabetesatlas.org

Alkurdi A, Alkurdi M, Alhamid M, et al. Prediabetes in Syria and its associated factors: a single-center cross-sectional study. BMC Endocr Disord. 2022;22(1):218.

Patel SA, Cunningham SA, Tandon N, Kinra S. Increments in metabolic and cardiovascular risk factors in South Asian populations: a structured review. J Prim Care Community Health. 2020;11:1–9.

Atabaki-Pasdar N, Ohlsson M, Viby-Mogensen J, et al. Predicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study. PLoS Med. 2020;17(6):e1003149. [Cited here as representative cardiometabolic risk study.]

Alhouri A, Albawab N, Albawab K, et al. Syrians’ awareness of cardiovascular disease risk factors and warning indicators: a descriptive cross-sectional study. Sci Rep. 2023;13(1):6562.

Khalil AH, Haddad H, Alia M, et al. Assessment of awareness toward hypertension and diabetes mellitus: Syrian cross-sectional study. BMC Public Health. 2023;23(1):786.

Garry S, Abebe R, Blanchet K, et al. Clinical outcomes in a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a cohort analysis using routine data. PLoS Med. 2021;18(1):e1003444.

Garry S, Abebe R, Kester J, et al. Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study. Health Policy Plan. 2020;35(9):1168–78.

Albawab N, Junbolat B, Almohamad A, et al. Knowledge and awareness of type 2 diabetes complications in conflict-affected regions: a cross-sectional study in Homs, Syria. Cureus. 2024;16(9):e68686.

Budreviciute A, Damiati S, Sabir DK, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:574111.




DOI: http://dx.doi.org/10.52155/ijpsat.v57.2.8186

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Abdulah Abou Kaff

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.